Mereo BioPharma Group plc (MAH0) — Net Asset Quality Index
Mereo BioPharma Group plc (MAH0) has a Net Asset Quality Index of 89.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €45.92 Million minus total liabilities of €5.00 Million yields net assets of €40.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Mereo BioPharma Group plc to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Mereo BioPharma Group plc Net Asset Quality Index Over Time (2016–2025)
This chart shows how Mereo BioPharma Group plc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 89.1%, representing net assets of €40.92 Million against total assets of €45.92 Million EUR. Explore MAH0 cash generation efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Mereo BioPharma Group plc (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Mereo BioPharma Group plc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see MAH0 stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.1% | €40.92 Million | €45.92 Million | €5.00 Million | ▲ +9.3 pp |
| 2024 | 79.8% | €60.97 Million | €76.39 Million | €15.42 Million | ▲ +3.8 pp |
| 2023 | 76.0% | €50.54 Million | €66.50 Million | €15.96 Million | ▲ +5.8 pp |
| 2022 | 70.2% | €61.87 Million | €88.08 Million | €26.21 Million | ▲ +0.6 pp |
| 2021 | 69.6% | €88.00 Million | €126.42 Million | €38.41 Million | ▲ +93.4 pp |
| 2020 | -23.8% | €-14.97 Million | €62.95 Million | €77.92 Million | ▼ -70.3 pp |
| 2019 | 46.6% | €40.26 Million | €86.45 Million | €46.19 Million | ▼ -2.1 pp |
| 2018 | 48.7% | €32.77 Million | €67.28 Million | €34.51 Million | ▼ -16.1 pp |
| 2017 | 64.9% | €62.48 Million | €96.34 Million | €33.85 Million | ▼ -26.5 pp |
| 2016 | 91.3% | €79.26 Million | €86.76 Million | €7.51 Million | — |